All Posts: Cancer Cell Biology Program News

• Bench to Bedside – DTP Webinars

  NCI Drug Development Webinars: How to Advance Therapeutic Candidate from Bench to Bedside Research Challenge Navigating through Investigational New Drug (IND)-enabling activities and acquiring the full set of resources for the preclinical stage of drug development Workshop Goals and Target Audience Provide researchers who are interested in  preclinical product development of anti-cancer agents with a […]

  Category: Cancer Cell Biology Program News

• Immunotherapy before targeted therapy extends OS in metastatic melanoma

  November 16, 2021 – Patients with BRAF V600 mutation-positive metastatic melanoma who received an immune checkpoint inhibitor combination followed by targeted therapy survived longer than those who received the reverse sequence, according to study findings. Results of the randomized phase 3 DREAMseq trial — presented during the inaugural ASCO Plenary Series — challenge existing treatment standards. Read […]

  Category: Cancer Cell Biology Program News